27
Participants
Start Date
March 31, 2009
Primary Completion Date
June 30, 2010
Study Completion Date
November 30, 2010
Sildenafil
"Participants will receive sildenafil for 12 weeks with the following therapy:~50 mg of oral sildenafil three times a day (TID) increased to 100 mg TID as tolerated in adults and children greater than 50 kg; 1 mg/kg sildenafil TID without dose escalation in children less than 50 kg"
Children's Hospital and Research Institute Oakland, Oakland
Lead Sponsor
Carelon Research
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH